Oncogenic K-Ras mutation involving tumor progression further increased the Ras protein level in ApcMin/+; K-RasG12DLA2 mouse tumors compared with that in ApcMin/+ mouse tumors (Fig. 4a). Here, KRAS is linked to neoplasm.